JP2016527259A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527259A5 JP2016527259A5 JP2016530495A JP2016530495A JP2016527259A5 JP 2016527259 A5 JP2016527259 A5 JP 2016527259A5 JP 2016530495 A JP2016530495 A JP 2016530495A JP 2016530495 A JP2016530495 A JP 2016530495A JP 2016527259 A5 JP2016527259 A5 JP 2016527259A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- direct bond
- compound
- alkyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13178543 | 2013-07-30 | ||
| EP13178543.8 | 2013-07-30 | ||
| PCT/EP2014/066273 WO2015014836A1 (en) | 2013-07-30 | 2014-07-29 | Substituted pyridine-piperazinyl analogues as rsv antiviral compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016527259A JP2016527259A (ja) | 2016-09-08 |
| JP2016527259A5 true JP2016527259A5 (enExample) | 2017-08-31 |
| JP6397912B2 JP6397912B2 (ja) | 2018-09-26 |
Family
ID=48874955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530495A Expired - Fee Related JP6397912B2 (ja) | 2013-07-30 | 2014-07-29 | Ｒｓｖ抗ウイルス化合物としての置換ピリジンピペラジニルアナログ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20160168124A1 (enExample) |
| EP (1) | EP3027608B1 (enExample) |
| JP (1) | JP6397912B2 (enExample) |
| KR (1) | KR102297433B1 (enExample) |
| CN (1) | CN105683183B (enExample) |
| AU (1) | AU2014298561B8 (enExample) |
| CA (1) | CA2914762C (enExample) |
| EA (1) | EA027732B1 (enExample) |
| ES (1) | ES2724577T3 (enExample) |
| WO (1) | WO2015014836A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020008061A (es) * | 2018-01-31 | 2020-09-09 | Janssen Sciences Ireland Unlimited Co | Pirazolopirimidinas sustituidas con cicloalquilo que tienen actividad contra vrs. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL147465B1 (en) * | 1984-03-26 | 1989-06-30 | Janssen Pharmaceutica Nv | Method of obtaining novel pyridazionoamine compounds |
| US5001125A (en) | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| US20080194574A1 (en) * | 2003-12-16 | 2008-08-14 | Axxima Pharmaceuticals Ag | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| MY145822A (en) | 2004-08-13 | 2012-04-30 | Neurogen Corp | Substituted biaryl piperazinyl-pyridine analogues |
| WO2008008453A1 (en) | 2006-07-14 | 2008-01-17 | Schering Corporation | Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| JP2010518064A (ja) * | 2007-02-12 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｄおよび関連状態の治療のためのピペラジン誘導体 |
| EP2149373A1 (en) | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7 receptor ligands and compositions comprising the same |
| BR112012002331A2 (pt) * | 2009-08-05 | 2019-09-24 | Versitech Ltd | composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica |
| JPWO2011062194A1 (ja) * | 2009-11-18 | 2013-04-04 | 武田薬品工業株式会社 | アミノピリジン誘導体 |
| US20110224229A1 (en) * | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Novel Crystalline Form |
| WO2011143129A1 (en) | 2010-05-13 | 2011-11-17 | Amgen Inc. | Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
| US20120142701A1 (en) | 2010-05-28 | 2012-06-07 | The University Of Hong Kong | Compounds and methods for the treatment of proliferative diseases |
| GB201010193D0 (en) * | 2010-06-17 | 2010-07-21 | Respivert Ltd | Medicinal use |
| LT3002278T (lt) * | 2011-03-15 | 2017-06-26 | Astellas Pharma Inc. | Guanidino junginys |
-
2014
- 2014-07-29 KR KR1020167002162A patent/KR102297433B1/ko not_active Expired - Fee Related
- 2014-07-29 EA EA201690300A patent/EA027732B1/ru not_active IP Right Cessation
- 2014-07-29 EP EP14744362.6A patent/EP3027608B1/en active Active
- 2014-07-29 CN CN201480043020.5A patent/CN105683183B/zh not_active Expired - Fee Related
- 2014-07-29 JP JP2016530495A patent/JP6397912B2/ja not_active Expired - Fee Related
- 2014-07-29 CA CA2914762A patent/CA2914762C/en active Active
- 2014-07-29 US US14/908,866 patent/US20160168124A1/en not_active Abandoned
- 2014-07-29 WO PCT/EP2014/066273 patent/WO2015014836A1/en not_active Ceased
- 2014-07-29 ES ES14744362T patent/ES2724577T3/es active Active
- 2014-07-29 AU AU2014298561A patent/AU2014298561B8/en not_active Ceased
-
2017
- 2017-06-23 US US15/632,027 patent/US10150761B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537203A5 (enExample) | ||
| JP2015500843A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2015512931A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| JP2016525102A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| JP2016507575A5 (enExample) | ||
| JP2015504081A5 (enExample) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2017514910A5 (enExample) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| JP2016523955A5 (enExample) | ||
| JP2017517565A5 (enExample) | ||
| JP2015500223A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2015521156A5 (enExample) | ||
| TN2015000386A1 (en) | Formulations of organic compounds | |
| JP2016537338A5 (enExample) | ||
| JP2016515550A5 (enExample) |